4basebio PLC (AIM:4BB)

Revenue by Product

Financials in millions GBX. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Synthetic DNA and RNA Products	491.00K
Synthetic DNA and RNA Products Growth	97.98%
Licences and Royalties	15.00K
Licences and Royalties Growth	-25.00%

Revenue by Geography

Financials in millions GBX. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
United States	320.00K
United States Growth	97.53%
Europe	176.00K
Europe Growth	107.06%
Rest of World	10.00K
Rest of World Growth	-52.38%